Readoutin 45d
Telix Pharmaceuticals (Innovations) Pty Limited — 68Ga-PSMA-11
Phase 3 primary completion: PSMA PET Combined With MRI for the Detection of PCa.
- Date
- Jan 2027
- Type
- Readout
- Indication
- PCA
Readoutin 45d
Phase 3 primary completion: PSMA PET Combined With MRI for the Detection of PCa.
The weekly brief is free. Pro adds reminders 7 days and 1 day before.